<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044981"><TermName>LY293111</TermName><TermDefinition><DefinitionText>A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor antagonists.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>LY293111</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de antagonista del receptor B4 de leucotrieno.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
